Phase 4 DUET enrolled adults with NT1/NT2 or idiopathic hypersomnia (ESS >10) and showed ≥2-point ESS reductions in 82% of narcolepsy and 95% of hypersomnia participants. Normal-range ESS (≤10) was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results